Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
» How Much Pain Will Congress Inflict on These Opioid Drugmakers' Stocks?
How Much Pain Will Congress Inflict on These Opioid Drugmakers' Stocks?
How Much Pain Will Congress Inflict on These Opioid Drugmakers' Stocks?
Submitted by
admin
on March 30, 2017 - 10:57am
Source:
Motley Fool
News Tags:
congress
opioids
Mylan Labs
Purdue Pharma
Insys
Depomed
JNJ
Headline:
How Much Pain Will Congress Inflict on These Opioid Drugmakers' Stocks?
